Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Anti-HIV Agents

Known as: Agents, Anti-AIDS, aid drug, Anti AIDS Drugs 
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections… Expand
National Institutes of Health

Related topics

Related topics

48 relations

Narrower (40)

1,1-azobisformamideAldesleukinAmprenavirDelavirdine
Expand
AIDS therapyAntiviral AgentsIn BloodIntegrase
Expand

Broader (1)

Pharmaceutical Preparations

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Accurate Dereplication of Bioactive Secondary Metabolites from Marine-Derived Fungi by UHPLC-DAD-QTOFMS and a MS/HRMS Library
In drug discovery, reliable and fast dereplication of known compounds is essential for identification of novel bioactive… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Highly Cited
2012
Highly Cited
2012
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
Background:Obtaining tissue for pancreatic carcinoma diagnosis and biomarker assessment to aid drug development is challenging… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2012
Highly Cited
2012
Implementation of Anaphylaxis Management Guidelines: A Register-Based Study
Background Anaphylaxis management guidelines recommend the use of intramuscular adrenaline in severe reactions, complemented by… Expand
  • figure 1
  • figure 2
  • table 2
  • table 3
  • figure 3
Highly Cited
2004
Highly Cited
2004
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
Human C5a is a plasma protein with potent chemoattractant and pro-inflammatory properties, and its overexpression correlates with… Expand
Highly Cited
2004
Highly Cited
2004
Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs
RationaleDifferent stimuli, including pharmacological stimuli, induce different neuroanatomical profiles of c-fos expression. Can… Expand
  • table 2
2003
2003
Interactions of 1263W94 with Other Antiviral Agents in Inhibition of Human Cytomegalovirus Replication
ABSTRACT Inhibition of human cytomegalovirus (HCMV) by 1263W94 was additive dosewise in combination with ganciclovir, acyclovir… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
2002
2002
Effects of a P-glycoprotein inhibitor on brain and plasma concentrations of anti-human immunodeficiency virus drugs administered in combination in rats.
Most of the existing anti-human immunodeficiency virus agents enter the central nervous system (CNS) inefficiently and thus may… Expand
  • figure 1
  • table 1
Highly Cited
2001
Highly Cited
2001
Molecular Interactions of Cyclam and Bicyclam Non-peptide Antagonists with the CXCR4 Chemokine Receptor*
The non-peptide CXCR4 receptor antagonist AMD3100, which is a potent blocker of human immunodeficiency virus cell entry, is a… Expand
  • figure 2
  • figure 1
  • figure 3
  • table I
  • figure 5
Highly Cited
2001
Highly Cited
2001
Considering the Need for Empirically Grounded Drug Court Screening Mechanisms
A primary threat to the operative effectiveness of drug courts is high failure rates. Empirically supported screening devices… Expand
  • table 1
  • table 2
Highly Cited
1993
Highly Cited
1993
Roles for In Vitro Myelotoxicity Tests in Preclinical Drug Development and Clinical Trial Planning
Myelosuppression is the dose-limiting side effect for most anti-cancer and many anti-human immunodeficiency virus agents, which… Expand
  • table I
  • figure 2
  • figure 1
  • table II
  • figure 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE